EPHA1 and breast cancer: Recently, Nikas et al. meticulously summarized the results of preclinical studies incorporating BC cell lines/animal models, as well as studies showing the clinical significance of aberrant EPH/ephrin expression patterns in human material, and published their mini-review on EPHs/ephrins, with a focus on BC heterogeneity [20].